Korean company aims for 10 billion won in sales with highly accurate blood-based dementia diagnosis kit

Quantamatrix, a manufacturer of diagnostic and testing products, sells Alzheimer's Plus, a blood test that can diagnose dementia. The company is targeting the Korean Alzheimer's disease diagnostic market at about 200 billion won.